|
|
Genethera Inc
GTHR's Fundamental analysis
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
|
Genethera Inc 's sales fell
in III. Quarter 2022 from the same quarter a year ago.
Biotechnology & Pharmaceuticals industry recorded
growth of revenues by 23.86 %
Genethera Inc net loss deacreased by in III. Quarter 2022 year on year, Genethera Inc net loss increased by -48.51 % in III. Quarter 2022 year on year,
• More on GTHR's Growth
|
|
Genethera Inc
realized net loss in trailing twelve months.
|
| Company |
| |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.48.
• More on GTHR's Valuation
|
|
|
|
|
Genethera Inc
realized net loss in trailing twelve months.
|
| Company |
| |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.48.
| | | |
